dc.contributor.author |
Agüero, Fernando H., 1968- |
dc.contributor.author |
Gonzalez Zobl, Griselda |
dc.contributor.author |
Baena Díez, Jose M. |
dc.contributor.author |
Roman Degano, Irene |
dc.contributor.author |
Garcia Gil, Maria |
dc.contributor.author |
Alzamora, María Teresa |
dc.contributor.author |
Marrugat de la Iglesia, Jaume |
dc.contributor.author |
Comas Cufí, Marc |
dc.contributor.author |
Pera, Guillem |
dc.contributor.author |
Elosua Llanos, Roberto |
dc.contributor.author |
Ramos, Rafel |
dc.contributor.author |
Grau Magaña, Maria |
dc.date.accessioned |
2015-10-14T10:09:02Z |
dc.date.available |
2015-10-14T10:09:02Z |
dc.date.issued |
2015 |
dc.identifier.citation |
Agüero F, González-Zobl G, Baena-Díez JM, Dégano IR, Garcia-Gil M, Alzamora MT. Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders. Atherosclerosis. 2015 Sep;242(1):1-7. DOI: 10.1016/j.atherosclerosis.2015.06.054. |
dc.identifier.issn |
0021-9150 |
dc.identifier.uri |
http://hdl.handle.net/10230/24844 |
dc.description.abstract |
OBJECTIVE: To compare the prevalence of lower extremity peripheral artery disease (PAD) and to assess whether age-associated progression in ankle-brachial index (ABI) differs between individuals with chronic immune-mediated inflammatory diseases (CIID) and the general population. METHODS: Pooled analysis with data from individuals aged 50 years and older with ABI measurements, obtained from population-based cross-sectional studies conducted in Catalonia (Spain). Information on three CIID diagnoses (i.e., inflammatory bowel disease, systemic connective tissue disorders, and inflammatory polyarthropathies and spondylopathies, considered as one entity for purposes of analysis) was obtained from electronic medical records. To ascertain the statistical association between PAD and CIID, logistic regression models were fitted and adjusted for age, sex, and cardiovascular risk factors. We tested the interaction between age and CIID diagnosis for ABI values. RESULTS: We included 8799 individuals, 312 (3.6%) with CIID. The age-standardized prevalence of PAD was higher in the CIID group (12% vs. 6% in general population, p = 0.001), and the model adjusted for age, sex, and cardiovascular risk factors also showed higher risk in individuals with CIID [Odds Ratio (95% confidence interval) = 1.65 (1.15-2.38); p = 0.007]. The inflammatory polyarthropathies/spondylopathies diagnosis was significantly associated with PAD in the fully adjusted model [1.80 (1.18-2.75); p = 0.006]. The atherosclerotic process was accelerated in individuals with CIID, compared to the general population (p for interaction<0.001). CONCLUSION: In individuals with CIID, age-standardized prevalence of PAD was significantly higher than in the general population and the atherosclerotic process was accelerated. However, only inflammatory polyarthropathies/spondylopathies was associated with significant risk of PAD. |
dc.description.sponsorship |
Supported by grants from the Instituto de Salud Carlos III FEDER (Programa HERACLES RD12/0042; RedIAPP RD12/0005; CP12/ 03287), AGAUR (2014 SGR 240 and 2011BP-B00169 postdoctoral contract to IRD eBeatriu de Pinos Program co- financed by the European Commission), Health Research Fund (FIS 2003/HERMES PI20471; PI070403; ETES: I07/90415; FIS11/06765); and Ministry of Education and Science (SAF2003/1240). |
dc.format.mimetype |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Elsevier |
dc.relation.ispartof |
Atherosclerosis. 2015 Sep;242(1):1-7 |
dc.rights |
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/). http://dx.doi.org/10.1016/j.atherosclerosis.2015.06.054 |
dc.rights.uri |
http://creativecommons.org/licenses/by-ncnd/4.0/ |
dc.subject.other |
Reumatisme -- Epidemiologia |
dc.subject.other |
Malalties vasculars perifèriques |
dc.title |
Prevalence of lower extremity peripheral arterial disease in individuals with chronic immune mediated inflammatory disorders. |
dc.type |
info:eu-repo/semantics/article |
dc.identifier.doi |
http://dx.doi.org/10.1016/j.atherosclerosis.2015.06.054 |
dc.rights.accessRights |
info:eu-repo/semantics/openAccess |
dc.type.version |
info:eu-repo/semantics/publishedVersion |